Addiclenz (Deseret Biologicals, Inc.)
Welcome to the PulseAid listing for the Addiclenz drug offered from Deseret Biologicals, Inc.. This Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Standardized Chemical Allergen [EPC],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Deseret Biologicals, Inc. |
| NON-PROPRIETARY NAME: | Beta Vulgaris, Boldo, Chelidonium Majus, Petroselinum Sativum, Taraxacum Officinale, Arsenicum Album, Belladonna, Cobaltum Metallicum, Cuprum Metallicum, Iodium, Lycopodium Clavatum, Phosphoricum Acid |
| SUBSTANCE NAME: | BETA VULGARIS; PEUMUS BOLDUS LEAF; CHELIDONIUM MAJUS; PETROSELINUM CRISPUM; TARAXACUM OFFICINALE; ARSENIC TRIOXIDE; ATROPA BELLADONNA WHOLE; COBALT; COPPER; IODINE; LYCOPODIUM CLAVATUM SPORE; PHOSPHOR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Standardized Chemical Allergen [EPC],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2012-11-13 |
| END MARKETING DATE: | 2019-05-07 |
Addiclenz HUMAN PRESCRIPTION DRUG Details:
| Item Description | Addiclenz from Deseret Biologicals, Inc. |
| LABELER NAME: | Deseret Biologicals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3; 3; 3; 3; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [h) |
| START MARKETING DATE: | 2012-11-13 |
| END MARKETING DATE: | 2019-05-07 |
| PRODUCT ID: | 43742-0165_4cb169fb-e0ff-4b2e-91cf-6dd1aed37c27 |
| PRODUCT NDC: | 43742-0165 |
| APPLICATION NUMBER: | |
Other BETA VULGARIS; PEUMUS BOLDUS LEAF; CHELIDONIUM MAJUS; PETROSELINUM CRISPUM; TARAXACUM OFFICINALE; ARSENIC TRIOXIDE; ATROPA BELLADONNA WHOLE; COBALT; COPPER; IODINE; LYCOPODIUM CLAVATUM SPORE; PHOSPHOR Pharmaceutical Manufacturers / Labelers:
